These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 26772755)

  • 1. DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression.
    Borghesan M; Fusilli C; Rappa F; Panebianco C; Rizzo G; Oben JA; Mazzoccoli G; Faulkes C; Pata I; Agodi A; Rezaee F; Minogue S; Warren A; Peterson A; Sedivy JM; Douet J; Buschbeck M; Cappello F; Mazza T; Pazienza V; Vinciguerra M
    Cancer Res; 2016 Feb; 76(3):594-606. PubMed ID: 26772755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MacroH2A1 isoforms are associated with epigenetic markers for activation of lipogenic genes in fat-induced steatosis.
    Podrini C; Koffas A; Chokshi S; Vinciguerra M; Lelliott CJ; White JK; Adissu HA; Williams R; Greco A
    FASEB J; 2015 May; 29(5):1676-87. PubMed ID: 25526730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopositivity for histone macroH2A1 isoforms marks steatosis-associated hepatocellular carcinoma.
    Rappa F; Greco A; Podrini C; Cappello F; Foti M; Bourgoin L; Peyrou M; Marino A; Scibetta N; Williams R; Mazzoccoli G; Federici M; Pazienza V; Vinciguerra M
    PLoS One; 2013; 8(1):e54458. PubMed ID: 23372727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
    Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
    Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.
    Zhang C; Li H; Wang Y; Liu W; Zhang Q; Zhang T; Zhang X; Han B; Zhou G
    J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic perturbation of epigenome by inhibiting S-adenosylhomocysteine hydrolase elicits senescence through DNA damage response in hepatoma cells.
    Wu G; Wang N; Luo Y; Zhang Y; Wang P; Zhu Z; Gao Y; Du Z; Yang B
    Tumour Biol; 2017 May; 39(5):1010428317699117. PubMed ID: 28459194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
    Zhao R; Wang N; Huang H; Ma W; Yan Q
    Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma.
    Lo Re O; Fusilli C; Rappa F; Van Haele M; Douet J; Pindjakova J; Rocha SW; Pata I; Valčíková B; Uldrijan S; Yeung RS; Peixoto CA; Roskams T; Buschbeck M; Mazza T; Vinciguerra M
    Hepatology; 2018 Feb; 67(2):636-650. PubMed ID: 28913935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma.
    Wong CM; Ng YL; Lee JM; Wong CC; Cheung OF; Chan CY; Tung EK; Ching YP; Ng IO
    Hepatology; 2007 May; 45(5):1129-38. PubMed ID: 17464989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells.
    Chan DW; Lee JM; Chan PC; Ng IO
    Int J Cancer; 2008 Sep; 123(5):1043-52. PubMed ID: 18553387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MacroH2A1 and ATM Play Opposing Roles in Paracrine Senescence and the Senescence-Associated Secretory Phenotype.
    Chen H; Ruiz PD; McKimpson WM; Novikov L; Kitsis RN; Gamble MJ
    Mol Cell; 2015 Sep; 59(5):719-31. PubMed ID: 26300260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic combination therapy as a tumor-selective treatment approach for hepatocellular carcinoma.
    Venturelli S; Armeanu S; Pathil A; Hsieh CJ; Weiss TS; Vonthein R; Wehrmann M; Gregor M; Lauer UM; Bitzer M
    Cancer; 2007 May; 109(10):2132-41. PubMed ID: 17407132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
    Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
    Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
    J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma.
    Jueliger S; Lyons J; Cannito S; Pata I; Pata P; Shkolnaya M; Lo Re O; Peyrou M; Villarroya F; Pazienza V; Rappa F; Cappello F; Azab M; Taverna P; Vinciguerra M
    Epigenetics; 2016 Oct; 11(10):709-720. PubMed ID: 27646854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4
    Lo Re O; Mazza T; Giallongo S; Sanna P; Rappa F; Vinh Luong T; Li Volti G; Drovakova A; Roskams T; Van Haele M; Tsochatzis E; Vinciguerra M
    Theranostics; 2020; 10(2):910-924. PubMed ID: 31903159
    [No Abstract]   [Full Text] [Related]  

  • 19. Histone MacroH2A1: A Chromatin Point of Intersection between Fasting, Senescence and Cellular Regeneration.
    Lo Re O; Vinciguerra M
    Genes (Basel); 2017 Dec; 8(12):. PubMed ID: 29206173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone variant macroH2A1 rewires carbohydrate and lipid metabolism of hepatocellular carcinoma cells towards cancer stem cells.
    Lo Re O; Douet J; Buschbeck M; Fusilli C; Pazienza V; Panebianco C; Castracani CC; Mazza T; Li Volti G; Vinciguerra M
    Epigenetics; 2018; 13(8):829-845. PubMed ID: 30165787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.